These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24874284)

  • 41. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
    Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
    Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes.
    Rayhanabad J; Yegiyants S; Putchakayala K; Haig P; Romero L; Difronzo LA
    Am Surg; 2010 Oct; 76(10):1088-91. PubMed ID: 21105616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel node biopsy in breast cancer: five years experience from Denmark.
    Christiansen P; Friis E; Balslev E; Jensen D; Møller S;
    Acta Oncol; 2008; 47(4):561-8. PubMed ID: 18465323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Breast Cancer Res Treat; 2019 Jun; 175(3):713-719. PubMed ID: 30877405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
    van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
    Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
    Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sentinel lymph nodes in cancer of the oral cavity: is central step-sectioning enough?
    Thomsen JB; Christensen RK; Sørensen JA; Krogdahl A
    J Oral Pathol Med; 2007 Aug; 36(7):425-9. PubMed ID: 17617836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes.
    Zgajnar J; Besic N; Podkrajsek M; Hertl K; Frkovic-Grazio S; Hocevar M
    Eur J Cancer; 2005 Jan; 41(2):244-8. PubMed ID: 15661549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False-negative sentinel lymph node biopsy.
    van Wely BJ; Smidt ML; de Kievit IM; Wauters CA; Strobbe LJ
    Br J Surg; 2008 Nov; 95(11):1352-5. PubMed ID: 18844270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the presence of small volume disease in the sentinel node an indication for axillary clearance?
    Patten DK; Leff DR; Wani Z; Cleator SJ; Palmieri C; Coombes RC; Hadjiminas DJ
    Breast; 2013 Feb; 22(1):70-3. PubMed ID: 22721758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.